TickerFacts.

A business in context

TGTX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-06 · 0001437749-26-026608

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001437749-26-025955

  3. 8-K · Current report

    Report date 2026-08-03 · 0001437749-26-025304 · Items 2.02,9.01

  4. 4 · Ownership change

    Report date 2026-06-11 · 0001437749-26-020679

  5. 4 · Ownership change

    Report date 2026-06-11 · 0001437749-26-020677

  6. 4 · Ownership change

    Report date 2026-06-11 · 0001437749-26-020676

  7. 4 · Ownership change

    Report date 2026-06-11 · 0001437749-26-020675

  8. 4 · Ownership change

    Report date 2026-06-11 · 0001437749-26-020673

  9. 8-K · Current report

    Report date 2026-06-11 · 0001437749-26-020491 · Items 5.07

  10. 8-K · Current report

    Report date 2026-06-03 · 0001437749-26-019262 · Items 8.01,9.01

  11. 8-K · Current report

    Report date 2026-05-27 · 0001437749-26-018586 · Items 8.01,9.01

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001437749-26-015246

  13. 8-K · Current report

    Report date 2026-05-06 · 0001437749-26-015013 · Items 2.02,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-06-11 · 0001437749-26-014233

  15. 8-K · Current report

    Report date 2026-03-18 · 0001437749-26-009253 · Items 1.01,2.03,9.01

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001437749-26-006133

  17. 8-K · Current report

    Report date 2026-02-26 · 0001437749-26-005733 · Items 2.02,9.01

  18. 4 · Ownership change

    Report date 2026-01-28 · 0001437749-26-002439

  19. 8-K · Current report

    Report date 2026-01-13 · 0001437749-26-001194 · Items 7.01,9.01

  20. 4 · Ownership change

    Report date 2026-01-08 · 0001437749-26-001016

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001437749-25-033363

  22. 8-K · Current report

    Report date 2025-11-03 · 0001437749-25-032658 · Items 2.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001437749-25-025745

  24. 8-K · Current report

    Report date 2025-08-04 · 0001437749-25-024480 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-06-12 · 0001437749-25-020335 · Items 5.07,9.01

  26. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001437749-25-015804

  27. 8-K · Current report

    Report date 2025-05-05 · 0001437749-25-014402 · Items 2.02,9.01

  28. DEF 14A · Proxy statement

    Report date 2025-06-12 · 0001437749-25-013860

  29. 10-K · Annual report

    Report date 2024-12-31 · 0001437749-25-005908

  30. 8-K · Current report

    Report date 2025-03-03 · 0001437749-25-005802 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-01-14 · 0001437749-25-001106 · Items 7.01,9.01

  32. SC 13G/A · Ownership disclosure

    0000902664-24-006638

  33. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001437749-24-033948

  34. 8-K · Current report

    Report date 2024-11-04 · 0001437749-24-033055 · Items 2.02,9.01

  35. SC 13G/A · Ownership disclosure

    0002012383-24-000117

  36. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001437749-24-025853

  37. 10-K/A · Annual report

    Report date 2023-12-31 · 0001437749-24-025850

  38. 8-K · Current report

    Report date 2024-08-02 · 0001437749-24-024718 · Items 1.01,1.02,2.02,8.01,9.01

  39. 8-K · Current report

    Report date 2024-06-14 · 0001437749-24-020510 · Items 5.02,5.03,5.07,9.01

  40. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001437749-24-014849

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 5 transaction rows5AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

5 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-11
2026-06-15
Lonial SagarA · Grant / award
Acquired
Stock Tracking Unit
Derivative security
8325.00.0
2026-06-11
2026-06-15
HUME DANIELA · Grant / award
Acquired
Stock Tracking Unit
Derivative security
8325.00.0
2026-06-11
2026-06-15
Hoberman KennethA · Grant / award
Acquired
Stock Tracking Unit
Derivative security
8325.00.0
2026-06-11
2026-06-15
Echelard YannA · Grant / award
Acquired
Stock Tracking Unit
Derivative security
8325.00.0
2026-06-11
2026-06-15
Charney Laurence NA · Grant / award
Acquired
Stock Tracking Unit
Derivative security
8325.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001001316TG THERAPEUTICS, INC.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
529900X21UKABN9NJ529
GLEIF legal name
TG Therapeutics, Inc.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2021-07-19T05:07:28Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • TG Therapeutics · alias · wikidata
  • MANHATTAN PHARMACEUTICALS INC · former SEC name · 2003-03-10 to 2012-04-27
  • ATLANTIC TECHNOLOGY VENTURES INC · former SEC name · 2000-08-14 to 2003-03-10
  • ATLANTIC PHARMACEUTICALS INC · former SEC name · 1996-11-07 to 2000-02-04
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$329.00M$350.21M
2023-12-31$233.66M$256.05M
2022-12-31$2.79M$3.18M
2021-12-31$6.69M$8.24M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗